Lōkahi Therapeutics
A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.
About
Lōkahi Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for debilitating neurological disorders. The company's lead candidate, LKT-144, is currently in Phase 2 trials for the treatment of amyotrophic lateral sclerosis (ALS). Lōkahi Therapeutics aims to address significant unmet medical needs in the neurology space through a combination of scientific rigor and strategic partnerships. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does Lōkahi Therapeutics do?
Lōkahi Therapeutics is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Healthcare, Neurology. It is based in La Jolla, California, USA and was founded in 2017. Public records show about 10 people and $63M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Lōkahi Therapeutics raised?
Lōkahi Therapeutics has raised a total of $63M in funding. The most recent round on record is Series B.
Where is Lōkahi Therapeutics headquartered?
Lōkahi Therapeutics is headquartered in La Jolla, California, USA.
When was Lōkahi Therapeutics founded?
Lōkahi Therapeutics was founded in 2017.
What industry does Lōkahi Therapeutics operate in?
Lōkahi Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Neurology, Biotech.
How many employees does Lōkahi Therapeutics have?
Lōkahi Therapeutics has approximately 10 people on record.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.